Seeking Alpha

Sharif Galal

Sharif Galal
Send Message
View as an RSS Feed
View Sharif Galal's Comments BY TICKER:

Latest comments  |  Highest rated
  • Cellceutix Overvalued By 90-99% [View article]
    Mark Kroenke JUNO IPO'd this year.

    Priced at $24 a share and backed by Goldman Sachs and J.P. Morgan...

    Debuting on the Nasdaq... Not an uplisting from the OTC

    No Comparison.
    Jan 3, 2015. 06:00 PM | Likes Like |Link to Comment
  • Cellceutix Overvalued By 90-99% [View article]
    On the point made above by "someconcerns", Ben Sharvy you make a valid arguments in your article regarding the composition of the board. Yeah, sure, you missed out on two board members whose addition do not solve the issue of corporate governance. It's too bad your oversight has resulted in your article being discredited by 95% of the comments...
    Jan 3, 2015. 03:49 PM | 1 Like Like |Link to Comment
  • The Crash Of Oil Prices Could Be The Opportunity Of The Decade [View article]
    Agreed, I think it's a bit early to be calling a bottom on Oil sensitive stocks... That being said calling the :tops" or "Bottoms" on anything is dangerous game. The author did his Due Diligence and found the shares of COP to be fairly valued given the current events and the possible future trajectory of oil prices.

    With OPEC's decision not to cut production I think we've yet to see how low oil prices will fall.
    Nov 30, 2014. 03:41 PM | 1 Like Like |Link to Comment
  • At the close [View news story]
    Investors definitely feeling a stronger economy is emerging
    Oct 29, 2014. 09:11 PM | 1 Like Like |Link to Comment
  • Cellceutix Eyeing A $5B Annual Market With Potential Caner Research Breakthrough [View article]
    I'm more than a little concerned with some of the wording used by Leo Ehrlich uses in his forward looking statements.

    I'd love to hear how Bio Pharma wasn't able to "crack the code" on the P53 tumor suppressor protein... yet apparently CTIX has? At the same time they've found a possible "treatment" for autism (KM-391) and another for psoriasis (KM-133)? Quite ambitious.

    "In our case, the active moeity of the compound is already an approved drug in another indication, not psoriasis" - Leo Ehrlich
    What other "indication"??? That would've been nice to have mentioned.

    I'm sure there have been more recent updates to the status of Kevetrin and its drug resistant cancer, and I encourage anyone who has input with solid backup to contribute, but in the mean time, I find it disconcerting that Leo refers to the drug as having the ability to "shrink" tumors. If I read correctly at the point of time this article was written the rhetoric (and accompanying graphs) is that the drug "inhibits growth" does not "shrink" tumors.

    "Even before we filed the IND, some of the largest biotechs in the world contacted us, wanting to be appraised of what's happening during the clinical trial." - Leo Ehrlich
    I'm sure they're well informed now on the efficacy of the drug. Has there been any more interest now that the trails have progressed?

    Worth noting that CTIX did manage to get into Dana-Faber/Harvard Cancer Institute to begin testing.
    Information on Kevetrin which should be releasing news on it's phase 1 study soon,
    Oct 23, 2014. 12:48 AM | Likes Like |Link to Comment
  • Cellceutix Eyeing A $5B Annual Market With Potential Caner Research Breakthrough [View article]
    A follow up on the current situation at CTIX would be a great Article Mr. Zehr
    Oct 22, 2014. 11:39 PM | Likes Like |Link to Comment
  • NanoViricides: House Of Cards With -80% Downside, 'Strong Sell' Recommendation [View article]
    We're getting pretty close to the end of 2014 here...
    Oct 22, 2014. 08:11 PM | 1 Like Like |Link to Comment
  • Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol [View article]
    Thank you for correcting my Mistake. I should have said "Common Stock Purchase agreements with Aspire Capital NOT "loans"

    More Info here:
    Sep 16, 2014. 11:38 AM | Likes Like |Link to Comment
  • Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol [View article]
    Great Update Karin! I was pretty skeptical about the acquisition of Polymedix's pipeline awhile back and saw it as a move that was not in the best interest of the company at the time due to the balance sheet structure. I felt they were biting off more than they could chew. Miraculously, CTIX recieved additional funding and support in the form of additional loans and is moving forward. I bought in and am in it for the long haul.

    I think talk of an uplisting is good and all but there are lots of requirements that I believe the company will have to meet first. They're gearing up and prepare to see this stock on many people's radars soon. I would'nt be surprised to see this at 4 dollars by year end or higher.. the tricky is keeping yourself from bagging the gain and remaining disciplined enough to take a multibagger some 5 years down the road when the shares are much MUCH higher.
    Sep 14, 2014. 10:53 PM | 3 Likes Like |Link to Comment
  • Gigamon -28.6% AH on Q2 warning [View news story]
    2nd quarter in a row. Doesn't look to good. 2 quarters in a row with the same excuse... I'm not buying it this time and I'd be surprised if anyone else would be. The numbers should tell an interesting story when they come out the 24th of July.
    Jul 8, 2014. 06:05 PM | Likes Like |Link to Comment
  • Tesla Motors' (TSLA) CEO Elon Musk on Q1 2014 Results - Earnings Call Transcript [View article]
    Transcript looks fine. Lots of very closely related questions. Lots of focus on gross margins. They seem confident that North America demand is still situated to grow for the model S. News on the Model X being delayed is not a good sign for the price reaction of the stock and the sentiment of buyers. Also seems like the gigafactory is behind schedule. Overall I think there has not been a significant change in the story to warrant any selling and the 7 some % drop after hours is the result of a run up right before earnings by retail investors looking to grab an easy lunch. They were hoping for some announcement that would drive it up and none came.

    It will be interesting to see what happens this morning, but doubtfully exciting.
    May 8, 2014. 05:18 AM | Likes Like |Link to Comment
  • What Are The Implications Of Bill Gates Potentially Selling Off All His Microsoft Stock? [View article]
    May 7, 2014. 05:49 AM | Likes Like |Link to Comment
  • What Are The Implications Of Bill Gates Potentially Selling Off All His Microsoft Stock? [View article]
    I'd think he is using it to give back via philanthropic investments.
    May 7, 2014. 05:47 AM | 2 Likes Like |Link to Comment
  • The Key Event That Will Signal The Next Bear Market [View article]
    Excellent Article Eric. Really enjoyed reading your take on market technical and the break down of the types of breaks of the 200 moving day average, all blended with a hint of fundamental analysis. Great article.

    What do you view as a good place to be when the market does confirm it is in a bear market? Do you switch to bonds or prefer to short certain stocks?
    Mar 13, 2014. 05:16 AM | 4 Likes Like |Link to Comment
  • Growth In Network Tools Creates A Rising Tide For Gigamon [View article]
    There's a lot of movement from some of the largest customers today from oracle and SAP towards e-Government solutions. Developing countries are picking up the pace of providing E-Government solutions to replace the tedious and very outdated silo and even paper based systems they have today. From first glance, and read about what Gigamon is providing I'd say this company could double in value within a year, if it is not acquired first. The number one obstacle seems to be what the what Zeus, the author of this article, and others point out as "confusion" or lack interest in taking time to understand what Gigamon does.

    Though I'm not an IT guy I'm hoping to write an article that explains the business and product a bit and go into the financials.
    Mar 12, 2014. 01:21 PM | Likes Like |Link to Comment